BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34041587)

  • 1. An Analysis of Biosynthesis Gene Clusters and Bioactivity of Marine Bacterial Symbionts.
    Viju N; Punitha SMJ; Satheesh S
    Curr Microbiol; 2021 Jul; 78(7):2522-2533. PubMed ID: 34041587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivity Screening and Gene-Trait Matching across Marine Sponge-Associated Bacteria.
    Gavriilidou A; Mackenzie TA; Sánchez P; Tormo JR; Ingham C; Smidt H; Sipkema D
    Mar Drugs; 2021 Jan; 19(2):. PubMed ID: 33573261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing regulatory networks in Actinobacteria for natural product discovery.
    Augustijn HE; Roseboom AM; Medema MH; van Wezel GP
    J Ind Microbiol Biotechnol; 2024 Jan; 51():. PubMed ID: 38569653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Sequencing and analyses of Two Marine Fungi from the North Sea Unraveled a Plethora of Novel Biosynthetic Gene Clusters.
    Kumar A; Sørensen JL; Hansen FT; Arvas M; Syed MF; Hassan L; Benz JP; Record E; Henrissat B; Pöggeler S; Kempken F
    Sci Rep; 2018 Jul; 8(1):10187. PubMed ID: 29976990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomics Approaches in Discovery and Development of New Bioactive Compounds from Marine Actinomycetes.
    Mahapatra GP; Raman S; Nayak S; Gouda S; Das G; Patra JK
    Curr Microbiol; 2020 Apr; 77(4):645-656. PubMed ID: 31069462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutically active secondary metabolites of marine actinobacteria.
    Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
    Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine Sponge and Octocoral-Associated Bacteria Show Versatile Secondary Metabolite Biosynthesis Potential and Antimicrobial Activities against Human Pathogens.
    Almeida JF; Marques M; Oliveira V; Egas C; Mil-Homens D; Viana R; Cleary DFR; Huang YM; Fialho AM; Teixeira MC; Gomes NCM; Costa R; Keller-Costa T
    Mar Drugs; 2022 Dec; 21(1):. PubMed ID: 36662207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
    Subramani R; Aalbersberg W
    Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytoplankton trigger the production of cryptic metabolites in the marine actinobacterium Salinispora tropica.
    Chhun A; Sousoni D; Aguiló-Ferretjans MDM; Song L; Corre C; Christie-Oleza JA
    Microb Biotechnol; 2021 Jan; 14(1):291-306. PubMed ID: 33280260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome mining for ribosomally synthesised and post-translationally modified peptides (RiPPs) reveals undiscovered bioactive potentials of actinobacteria.
    Poorinmohammad N; Bagheban-Shemirani R; Hamedi J
    Antonie Van Leeuwenhoek; 2019 Oct; 112(10):1477-1499. PubMed ID: 31123844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and enhancement of caerulomycin A biosynthesis in marine-derived Actinoalloteichus sp. AHMU CJ021 by combinatorial genome mining strategies.
    Xie Y; Chen J; Wang B; Chen T; Chen J; Zhang Y; Liu X; Chen Q
    Microb Cell Fact; 2020 Aug; 19(1):159. PubMed ID: 32762690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Secondary Metabolite Gene Clusters in the
    Naughton LM; Romano S; O'Gara F; Dobson ADW
    Front Microbiol; 2017; 8():1494. PubMed ID: 28868049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phylogenetic and evolutionary analysis of antimycin biosynthesis.
    Joynt R; Seipke RF
    Microbiology (Reading); 2018 Jan; 164(1):28-39. PubMed ID: 29111964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms.
    Li T; Ding T; Li J
    Mini Rev Med Chem; 2019; 19(2):138-164. PubMed ID: 28969543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Alkaloids from Marine Actinobacteria: Discovery and Characterization.
    De Rop AS; Rombaut J; Willems T; De Graeve M; Vanhaecke L; Hulpiau P; De Maeseneire SL; De Mol ML; Soetaert WK
    Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilithic Biofilms in Lake Baikal: Screening and Diversity of PKS and NRPS Genes in the Genomes of Heterotrophic Bacteria.
    Sukhanova E; Zimens E; Kaluzhnaya O; Parfenova V; Belykh O
    Pol J Microbiol; 2018; 67(4):501-516. PubMed ID: 30550237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metagenomic Exploration of the Marine Sponge
    Storey MA; Andreassend SK; Bracegirdle J; Brown A; Keyzers RA; Ackerley DF; Northcote PT; Owen JG
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivity-HiTES Unveils Cryptic Antibiotics Encoded in Actinomycete Bacteria.
    Moon K; Xu F; Zhang C; Seyedsayamdost MR
    ACS Chem Biol; 2019 Apr; 14(4):767-774. PubMed ID: 30830740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome sequence analysis and bioactivity profiling of marine-derived actinobacteria, Brevibacterium luteolum, and Cellulosimicrobium funkei.
    Tanveer F; Shehroz M; Ali M; Xie Y; Abbasi R; Shinwari ZK; Yasmin A
    Arch Microbiol; 2021 Jul; 203(5):2491-2500. PubMed ID: 33677635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micrococcus spp. as a promising source for drug discovery: A review.
    Tizabi D; Hill RT
    J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37460166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.